Welcome to the e-CCO Library!

P072: Quantitative phase imaging for the characterisation of Crohn’s disease-derived intestinal strictures
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Bokemeyer*1, P. Tepasse1, L. Quill1, P. Lenz2, E. Rijcken3, M. Vieth4, S. Ketelhut5, F. Rieder6, B. Kemper7, D. Bettenworth1

Created: Friday, 22 February 2019, 9:41 AM
P072: Safety analysis of vedolizumab during pregnancy: Findings from a reproductive study in monkeys
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Crawford*, M. Friedman

Created: Thursday, 21 February 2019, 9:14 AM
P072: The involvement of extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) and Nicotinate Phosphoribosyltransferase (eNAPRT) in inflammatory bowel disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Colombo, G.(1);Ribaldone, D.G.(2);Caviglia, G.P.(3);Genazzani, A.(1);Travelli, C.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P072: The role of the rs8005161 polymorphism on pH-sensing G protein-coupled receptor GPR65 (TDAG8) signalling in intestinal inflammation
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Tcymbarevich I.1, Obialo N.2, Cosin-Roger J.1, Seuwen K.3, Rogler G.1,2, Misselwitz B.2, de Vallière C.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P072: TREM-1 stimulation ameliorates colitis in mice
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

H. W. Ma*1, 2, X. Che1, 2, D. H. Seo1, 2, J. H. Kim1, 2, D. H. Kim1, 
T. I. Kim1, W. H. Kim1, S. W. Kim1, 2, 3, J. H. Cheon1, 2, 3

Created: Friday, 22 February 2019, 9:49 AM
P073 Compartmentalised human gut immunity: studies of innate and adaptive lymphocyte distribution in the epithelium, lamina propria and GALT of healthy gut mucosa by flow cytometry
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Carrasco Garcia1,2, A. Rao1, E. Kokkinou1, S. Haapaniemi2,3, U. Lindforss4, M.E. Winberg2, M. Casado-Bedmar2, T. Fenton5, P. Jørgensen5, C. Nordenvall4, W. Agace5, Å.V. Keita2, J.D. Söderholm2,6, J. Mjösberg1,2

Created: Thursday, 30 January 2020, 10:12 AM
P0730: Inflammatory Bowel Disease Lifestyle Food and Exercise (IBDLiFE) study: a randomized controlled trial to investigate the effectiveness of a personalised diet and physical activity intervention for adults with inactive IBD in Aotearoax7x7x7 New Zealand
Year: 2025
Source: ECCO'25
Authors: Yapx7x7x7 J.(1)*;Wallx7x7x7 C.L.(2);Meredith-Jonesx7x7x7 K.(1);Iosuax7x7x7 E.(3);Osbornex7x7x7 H.(1);Michaelx7x7x7 S.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0731: Analysis of the short-term efficacy and risk factors of ustekinumab combined with surgical intervention in the management of perianal fistulizing Crohn's Disease: a single center real-world result
Year: 2025
Source: ECCO'25
Authors: Max7x7x7 K.(1)*;Lix7x7x7 Y.(1);Wengx7x7x7 F.(1);Yaox7x7x7 Y.(1); Wangx7x7x7 C.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0732: A cost comparison of treatment sequencing for Ulcerative Colitis: vedolizumab vs ustekinumab as a second-line biologic in anti-TNF-exposed patients in Canada
Year: 2025
Source: ECCO'25
Authors: Martinx7x7x7 M.(1);Zhoux7x7x7 J.Y.(2)*;Macx7x7x7 S.(2);Kaox7x7x7 K.E.(1);Johnstonx7x7x7 K.(1);Marshallx7x7x7 J.K.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0733: REALASA: Real-world effectiveness assessment of first-line 5-ASA for the treatment of Ulcerative Colitis in Sweden
Year: 2025
Source: ECCO'25
Authors: Christophersenx7x7x7 B.(1);Nielsenx7x7x7 L.(2);Landeirax7x7x7 M.(3);Guedesx7x7x7 S.(4)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0734: Real-World Experience of Curcumin+Qing Dai Reduces Biochemical and Intestinal Ultrasound Disease Markers in Patients with Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Krugliak Clevelandx7x7x7 N.(1)*;Dutyx7x7x7 C.(1);Bhondwex7x7x7 K.(1);Rubinx7x7x7 D.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0735: Early dietetic assessment predicts clinical efficacy of Exclusive Enteral Nutrition in adults with Crohn’s disease
Year: 2025
Source: ECCO'25
Authors: Chux7x7x7 M.(1x7x7x72x7x7x73)*;Dayx7x7x7 A.S.(1x7x7x73x7x7x74);Bogaticx7x7x7 D.(1x7x7x72x7x7x73);Hatzix7x7x7 M.(4);Chux7x7x7 S.K.(2);Costellox7x7x7 S.P.(1x7x7x72x7x7x73);Bryantx7x7x7 R.V.(1x7x7x72x7x7x73);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0736: Analysis of endoscopic recurrence risk factors in Crohn's disease after surgical treatment within 1 year
Year: 2025
Source: ECCO'25
Authors: Weix7x7x7 T.(1);Guox7x7x7 H.(1)*;Xiaomeix7x7x7 S.(1);Lex7x7x7 H.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0738: Apulian Network for Inflammatory Bowel Disease (AN-IBD) safety profile: Pilot data
Year: 2025
Source: ECCO'25
Authors: Ditonno x7x7x7 I.(1);Contaldo x7x7x7 A.(1)*;Dell'Aquila x7x7x7 P.(1);Suriano x7x7x7 V.(1);Bossa x7x7x7 F.(2);Annese x7x7x7 M.(2);Perri x7x7x7 F.(2);Mazzuoli x7x7x7 S.(3);Guglielmi x7x7x7 F.W.(3);Bringiotti x7x7x7 R.(4);Palmisano x7x7x7 C.M.(5);Pranzo x7x7x7 G.(5);Albano x7x7x7 F.(6);Neve x7x7x7 V.(6);Tonti x7x7x7 P.(6);Stasi x7x7x7 E.(7);Facciorusso x7x7x7 A.(7);Marzo x7x7x7 M.(8);Paiano x7x7x7 P.(8);Gatti x7x7x7 F.(9);Di Lorenzo x7x7x7 M.P.(9);Fanigliulo x7x7x7 L.(10);Panarese x7x7x7 A.(10);Allegretta x7x7x7 L.(11);Bucci x7x7x7 A.(12);Hadad x7x7x7 Y.(13);Pisani x7x7x7 A.(14);Sacco x7x7x7 R.(15);Tursi x7x7x7 A.(16);Principi x7x7x7 M.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0739: Treatment persistencex7x7x7 clinicalx7x7x7 and biological outcomes following an elective switch from intravenous to subcutaneous infliximab and vedolizumab
Year: 2025
Source: ECCO'25
Authors: Outtierx7x7x7 A.(1)*;Hoffertx7x7x7 Y.(2);De Dyckerx7x7x7 E.(1);Geensx7x7x7 P.(1);Lambrechtsx7x7x7 T.(1);Loddewijkxx7x7x7 E.(1);Papsx7x7x7 A.(1);Verstocktx7x7x7 B.(1);Sabinox7x7x7 J.(1);Vermeirex7x7x7 S.(1);Ferrantex7x7x7 M.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P073: Age dependent decrease in gut-homing CD4 lymphocytes
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Oh S.*1, Lee C.H.2, Hsu P.3, Hu M.4, Nanan B.4, Gaskin K.2, Leong R.5, Nanan R.4

Created: Wednesday, 20 February 2019, 10:36 AM
P073: An increased autophagy and decreased apoptosis is detected in intestinal fibroblasts from Crohn’s Disease patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Gisbert-Ferrandiz, L.(1);Queralt, M.(1);Cosín-Roger, J.(2);Coll, S.(1);Bauset, C.(1);Ortiz-Masia, D.(3);Llau, J.(1);Navarro-Vicente, F.(4);Calatayud, S.(1);Barrachina, M.D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P073: Changes in gut microbial signatures differentiate behavioural Crohn’s disease phenotypes; an in silico approach
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Dovrolis1, G. Kolios1*, I. Drygiannakis2, E. Filidou1, L. Kandilogiannakis1, K. Arvanitidis1, I. Tentes3, V. Valatas2

Created: Thursday, 21 February 2019, 9:14 AM
P073: Eosinophil depletion partially protects from colonic inflammation, but increases colonic collagen deposition in a DSS colitis model
Year: 2022
Source: ECCO'22
Authors: Jacobs, I.(1);Deleu, S.(2);Cremer, J.(1,2);Guedelha Sabino, J.(2,3);Ferrante, M.(2,3);Vermeire, S.(2,3);Breynaert, C.(1,4);Verstockt, B.(2,3);Vanuytsel, T.(2,3);
Created: Friday, 11 February 2022, 3:52 PM
P073: Evaluation of DPPH free radical scavenging activity by HPLC technique: a screening method for drugs and nutrients used in inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M-L. Jelicic1, E. Brusac1, D. Amidzic Klaric1, B. Nigovic1, N. Turk*2, Z. Krznaric2, A. Mornar1

Created: Friday, 22 February 2019, 9:41 AM